Evaluating a decision support system for preventing blood clots in brain injury patients
Evaluation of the SCALED (SCaling AcceptabLE cDs) Approach for the Implementation of Interoperable CDS for Venous Thromboembolism Prevention - CDS Data
This study is testing a new system to help doctors prevent blood clots in adults who have suffered a brain injury.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT05628207 on ClinicalTrials.gov |
What this trial studies
This project aims to adapt an existing Clinical Decision Support (CDS) system to implement a venous thromboembolism (VTE) prevention guideline specifically for adult patients with traumatic brain injury (TBI). The study will involve seven institutions to scale, evaluate, and maintain this interoperable CDS system. By focusing on TBI patients, the project seeks to address a critical need in preventing VTE in trauma cases, leveraging previous experiences in guideline implementation.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are admitted to the hospital with a traumatic brain injury.
Not a fit: Patients who die within 24 hours of admission or those classified as 'comfort cares' during the first 72 hours, as well as those with mild TBI, may not benefit from this study.
Why it matters
Potential benefit: If successful, this could significantly reduce the incidence of venous thromboembolism in patients with traumatic brain injury.
How similar studies have performed: Other studies have shown success in implementing clinical decision support systems for VTE prevention, making this approach promising yet still focused on a specific patient population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18 and older * admitted with a TBI Exclusion Criteria: * Patients who die within 24 hours of hospital admission and patients documented as "comfort cares" during the first 72 hours of hospitalization or with mild TBI will be excluded from final analysis.
Where this trial is running
Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Study coordinator: Christopher Tignanelli, MD,MS
- Email: ctignane@umn.edu
- Phone: 612 625 7911
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.